Tag: Aprea Therapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aprea Therapeutics Inc.

Aprea Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters ...

Added to Collection on: 2019-10-07 04:15:00

Tags for this article:

Initial public offering
Finance
U.S. Securities and Exchange Commission
Financial economics
Money
Financial markets
Prospectus
Public offering
Securities Act
Registration statement
Morgan Stanley
Boston
Aprea Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in ...

Added to Collection on: 2020-12-28 12:56:15

Tags for this article:

Branches of biology
Cancer
Tumor suppressor genes
Lactams
Apoptosis
P53
Programmed cell death
Azacitidine
Tumor suppressor
Aprea Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
APRE Stock Price: $6 Target By Morgan Stanley

Added to Collection on: 2020-12-29 17:26:15

Tags for this article:

Branches of biology
Orphan drugs
Azacitidine
Lactams
Nucleosides
Triazines
P53
Aprea Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Palo Alto Investors, LLC Buys eHealth Inc, Biogen Inc, Gritstone Bio Inc, Sells Staar Surgical Co ...

Added to Collection on: 2021-05-18 23:37:30

Tags for this article:

Life Sciences
Corporate finance
Biotechnology
Specialty drugs
Stock market
Palo Alto, California
Silicon Valley
Alexion Pharmaceuticals
Biogen
Stock
Alexion Pharmaceuticals Inc.
Sunesis Pharmaceuticals Inc.
Rigel Pharmaceuticals, Inc
Staar Surgical Co
Aprea Therapeutics Inc.
Gritstone Bio Inc.

Click the tags to see associated articles and topics

View Article Details
Why Kindred Biosciences, Aprea, Catabasis And Inhibikase Are Moving Today

Added to Collection on: 2021-06-16 16:30:00

Tags for this article:

Chemical compounds
Organic compounds
Health care
Benzamides
Breakthrough therapy
Chloroarenes
Sulfonamides
Venetoclax
NASDAQ
Elanco
Short
Catabasis Pharmaceuticals
Kindred Biosciences Inc
Aprea Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Aprea Therapeutics Inc. (NASDAQ:APRE) Is Down -17.80 Percent Over The Past 30 Days ...

Added to Collection on: 2021-12-25 08:03:21

Tags for this article:

Financial markets
Finance
Stock market
Money
Share
Short
Stock
NASDAQ
Initial public offering
Public float
Mutual fund
Aprea Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Aprea Therapeutics, Inc. (NASDAQ:APRE) Receives $3.25 Average PT from Analysts

Added to Collection on: 2022-07-10 17:15:55

Tags for this article:

Economy of New York City
NASDAQ
New York City
Finance
Financial markets
Aprea Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Short Interest in Aprea Therapeutics, Inc. (NASDAQ:APRE) Increases By 18.5%

Added to Collection on: 2022-10-30 08:30:27

Tags for this article:

Alternative investment management companies
Hedge fund
Share price
Aprea Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details